The estimated Net Worth of Partners L P/Ilbiotechnolog... is at least $76.5 Million dollars as of 26 October 2012. Partners Ilbiotechnolog owns over 16,591 units of Ligand Pharmaceuticals stock worth over $76,454,327 and over the last 12 years Partners sold LGND stock worth over $0.
Partners has made over 1 trades of the Ligand Pharmaceuticals stock since 2012, according to the Form 4 filled with the SEC. Most recently Partners bought 16,591 units of LGND stock worth $252,017 on 26 October 2012.
The largest trade Partners's ever made was buying 16,591 units of Ligand Pharmaceuticals stock on 26 October 2012 worth over $252,017. On average, Partners trades about 16,591 units every 0 days since 2012. As of 26 October 2012 Partners still owns at least 741,627 units of Ligand Pharmaceuticals stock.
You can see the complete history of Partners Ilbiotechnolog stock trades at the bottom of the page.
Over the last 21 years, insiders at Ligand Pharmaceuticals have traded over $205,340,014 worth of Ligand Pharmaceuticals stock and bought 2,116,600 units worth $27,601,439 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Partners L P/Ilbiotechnolog..., and Partners L P/Ilbiotechnolog.... On average, Ligand Pharmaceuticals executives and independent directors trade stock every 22 days with the average trade being worth of $2,239,733. The most recent stock trade was executed by Octavio Espinoza on 28 August 2024, trading 753 units of LGND stock currently worth $50,090.
ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.
Ligand Pharmaceuticals executives and other stock owners filed with the SEC include: